Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
MicroPort CardioFlow Medtech Corp. ( (HK:2160) ) has shared an announcement.
MicroPort CardioFlow Medtech Corp. announced that its shareholders approved a merger agreement at an extraordinary general meeting held on December 15, 2025. The merger involves MicroPort CardioFlow CRM Limited and MicroPort Cardiac Rhythm Management Limited, with plans to issue new shares to complete the merger. This strategic move is expected to enhance the company’s market position and expand its product offerings in the cardiovascular sector.
The most recent analyst rating on (HK:2160) stock is a Hold with a HK$1.00 price target. To see the full list of analyst forecasts on MicroPort CardioFlow Medtech Corp. stock, see the HK:2160 Stock Forecast page.
More about MicroPort CardioFlow Medtech Corp.
MicroPort CardioFlow Medtech Corp. is a company in the medical technology industry, focusing on the development and manufacturing of cardiovascular devices. It operates with a market focus on innovative solutions for heart-related medical conditions.
Average Trading Volume: 5,283,651
Technical Sentiment Signal: Hold
Current Market Cap: HK$2.77B
Find detailed analytics on 2160 stock on TipRanks’ Stock Analysis page.